ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

FRANKLIN HANDEL M.D.

At A Glance: This Prescriber in 2012

Cardiovascular Disease

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

15,623Medicare Part D Prescriptions Filled, Including Refills

Rank: 6 out of 636

$1.13M Total Retail Price of All Prescriptions

Rank: 5 out of 636

1,085 Patients Receiving at Least One Drug in Part D
93%Patients 65 Years and Older
12% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Ohio
Lower avg

Schedule Two
Controlled Substances

N/A

Schedule Three
Controlled Substances

N/A

Risky Drugs to Seniors

0% of this provider’s 14,632 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 0%.

Brand Name Drugs

26% of this provider’s prescriptions were for brand-name drugs, compared to an average of 22%.

Prescription Price

$73 was the average price of a prescription from this provider, compared to $65 among peers.

Prescriptions per Patient

14 is the average number of prescriptions (including refills) per patient, compared to an average of 10.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Ohio
AMLODIPINE BESYLATE 1,314 1,234 1 7
ATORVASTATIN CALCIUM 1,107 1,033 2 9
METOPROLOL SUCCINATE 1,068 962 3 6
LISINOPRIL 995 924 4 1
WARFARIN SODIUM 861 846 5 8
SIMVASTATIN 810 758 6 4
CARVEDILOL 536 493 7 3
FUROSEMIDE 470 449 8 5
METOPROLOL TARTRATE 454 429 9 2
FLECAINIDE ACETATE 376 369 10 46
CRESTOR 343 282 11 17
ZETIA 299 285 12 28
PRAVASTATIN SODIUM 297 288 13 13
TOPROL XL 255 255 14 39
LOSARTAN POTASSIUM 245 232 15 16
LIPITOR 235 213 16 35
LISINOPRIL-HYDROCHLOROTHIAZIDE 231 225 17 32
CLOPIDOGREL 212 184 18 10
METFORMIN HCL 210 193 19 47
HYDROCHLOROTHIAZIDE 201 201 20 18
LEVOTHYROXINE SODIUM 198 177 21 30
OMEPRAZOLE 192 174 22 29
FENOFIBRATE 183 166 23 45
PLAVIX 165 150 24 12
DIOVAN 159 159 25 31
PRADAXA 150 149 26 23
ATENOLOL 147 134 27 14
LOSARTAN-HYDROCHLOROTHIAZIDE 144 138 28 40
TIKOSYN 143 143 29 55
KLOR-CON M20 127 122 30 33
DIGOXIN 127 121 30 15
ISOSORBIDE MONONITRATE ER 117 117 32 11
VYTORIN 105 105 33 87
POTASSIUM CHLORIDE 102 85 34 19
DIOVAN HCT 98 97 35 78
ALLOPURINOL 98 97 35 64
NIFEDIPINE ER 93 93 37 59
BYSTOLIC 89 86 38 36
NITROSTAT 85 72 39 22
DOXAZOSIN MESYLATE 77 77 40 62
MULTAQ 72 72 41 49
TRICOR 70 67 42 81
SERTRALINE HCL 68 59 43 66
LORAZEPAM 66 65 44 120
DILTIAZEM 24HR ER 66 66 44 26
RANEXA 64 64 46 25
DILTIAZEM ER 62 62 47 92
ENALAPRIL MALEATE 58 52 48 37
AMLODIPINE-ATORVASTATIN 55 52 49 234
GEMFIBROZIL 54 54 50 99
SYNTHROID 52 52 51 132
NEXIUM 51 33 52 56
CLONIDINE HCL 50 45 53 43
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on April 9, 2008.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.